137 related articles for article (PubMed ID: 168452)
1. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
Francis DL; Roy AC; Collier HO
Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452
[No Abstract] [Full Text] [Related]
2. Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines.
Butt NM; Collier HO; Cuthbert NJ; Francis DL; Saeed SA
Eur J Pharmacol; 1979 Feb; 53(4):375-8. PubMed ID: 217699
[TBL] [Abstract][Full Text] [Related]
3. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Collier HO; Cuthbert NJ; Francis DL
Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
Bocek RM; Beatty CH
Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
[No Abstract] [Full Text] [Related]
5. Radioprotection of mouse intestine by inhibitors of cyclic AMP phosphodiesterase.
Lehnert S
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):825-33. PubMed ID: 91600
[No Abstract] [Full Text] [Related]
6. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
7. Opiates, cyclic nucleotides, and xanthines.
Collier HO; Francis DL; Roy AC
Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
Nahorski SR; Rogers KJ
Neuropharmacology; 1976 Oct; 15(10):609-12. PubMed ID: 186725
[No Abstract] [Full Text] [Related]
9. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
McNeill JH; Brenner MJ; Muschek LD
Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
[No Abstract] [Full Text] [Related]
10. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
Schwabe U; Miyake M; Ohga Y; Daly JW
Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
[No Abstract] [Full Text] [Related]
11. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
Wells JN; Kramer GL
Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
[No Abstract] [Full Text] [Related]
12. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
Adachi K; Numano F
Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
[TBL] [Abstract][Full Text] [Related]
14. Effects of some inhibitiors of cyclic nucleotide phosphodiesterase on protein phosphorylation in isolated neurons and glia from rat brain.
Kinnier WJ; Wilson JE
Biochem Biophys Res Commun; 1977 Aug; 77(4):1369-76. PubMed ID: 197958
[No Abstract] [Full Text] [Related]
15. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
16. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
Manganiello V; Degerman E; Elks M
Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
[No Abstract] [Full Text] [Related]
17. Circadian periodicity a neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase.
Feldman JF
Science; 1975 Nov; 190(4216):789-90. PubMed ID: 173018
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini.
Gardner JD; Korman LY; Walker MD; Sutliff VE
Am J Physiol; 1982 Jun; 242(6):G547-51. PubMed ID: 6178297
[TBL] [Abstract][Full Text] [Related]
19. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
20. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
Prasad KN; Becker G; Tripathy K
Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
